Predict your next investment

Venture Capital
toucancapital.com

See what CB Insights has to offer

Investments

24

Portfolio Exits

8

Funds

3

About Toucan Capital

Toucan Capital specializes in seed and early stage investments in novel, emerging technologies. We are particularly interested in working with inventors, researchers, scientists, and entrepreneurs at the very beginning of their efforts to commercialize an invention or technology. We look for emerging technologies with broad potential to create multiple products and multiple ways to win.

Toucan Capital Headquarter Location

Maryland,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Toucan Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Toucan Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Toucan Capital Investments

24 Investments

Toucan Capital has made 24 investments. Their latest investment was in Inmune Bio as part of their Unattributed VC on July 7, 2017.

CBI Logo

Toucan Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/13/2017

Unattributed VC

Inmune Bio

$3.34M

Yes

1

11/7/2012

Series E - II

Vital Therapies

$60M

No

Delphi Ventures, DFJ DragonFund, HBM Healthcare Investments, Heights Capital Management, Landmark Capital, MedVenture Associates, Valley Ventures, and Versant Ventures

1

9/28/2012

Series E

Vital Therapies

$16M

No

Delphi Ventures, DFJ DragonFund, HBM Healthcare Investments, Heights Capital Management, Landmark Partners, MedVenture Associates, Valley Ventures, and Versant Ventures

6/23/2011

Series D

Subscribe to see more

$99M

Subscribe to see more

10

5/3/2011

Series E

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/13/2017

11/7/2012

9/28/2012

6/23/2011

5/3/2011

Round

Unattributed VC

Series E - II

Series E

Series D

Series E

Company

Inmune Bio

Vital Therapies

Vital Therapies

Subscribe to see more

Subscribe to see more

Amount

$3.34M

$60M

$16M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Delphi Ventures, DFJ DragonFund, HBM Healthcare Investments, Heights Capital Management, Landmark Capital, MedVenture Associates, Valley Ventures, and Versant Ventures

Delphi Ventures, DFJ DragonFund, HBM Healthcare Investments, Heights Capital Management, Landmark Partners, MedVenture Associates, Valley Ventures, and Versant Ventures

Sources

1

1

10

10

Toucan Capital Portfolio Exits

8 Portfolio Exits

Toucan Capital has 8 portfolio exits. Their latest portfolio exit was Inmune Bio on February 04, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/4/2019

IPO

$991

Public

3

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

2/4/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

$991

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Toucan Capital Fund History

3 Fund Histories

Toucan Capital has 3 funds, including Toucan Capital Fund II LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2002

Toucan Capital Fund II LP

Early-Stage Venture Capital

$120M

1

12/31/1998

Toucan Capital Fund I LP

Subscribe to see more

$99M

10

Toucan Capital Fund III LP

Subscribe to see more

$99M

10

Closing Date

12/31/2002

12/31/1998

Fund

Toucan Capital Fund II LP

Toucan Capital Fund I LP

Toucan Capital Fund III LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Amount

$120M

$99M

$99M

Sources

1

10

10

Toucan Capital Team

5 Team Members

Toucan Capital has 5 team members, including current Owner, Linda F. Powers.

Name

Work History

Title

Status

Robert F. Hemphill

Founder

Current

Linda F. Powers

Owner

Current

J. Kelly Ganjei

Chief Executive Officer

Former

Bruce Robertson

GIV Venture Partners, IGEN International, and Grace

Managing Director

Former

Phillip Singerman

Managing Director

Former

Name

Robert F. Hemphill

Linda F. Powers

J. Kelly Ganjei

Bruce Robertson

Phillip Singerman

Work History

GIV Venture Partners, IGEN International, and Grace

Title

Founder

Owner

Chief Executive Officer

Managing Director

Managing Director

Status

Current

Current

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.